Patent ID: 8153616
Filing Date: 2012-04-10
Classification: A61K,A61P

Abstract:
1. A method of treating dysfunctional uterine bleeding and of oral contraception, comprising orally administering to a woman in need of treatment for dysfunctional uterine bleeding and desiring oral contraception, over at least one treatment cycle of 28 days, one dosage unit comprising 3 mg of estradiol valerate daily for 2 days, then one dosage unit comprising 2 mg of estradiol valerate and 2 mg of dienogest daily for 5 days, then one dosage unit comprising 2 mg of estradiol valerate and 3 mg of dienogest daily for 17 days, then one dosage unit comprising 1 mg of estradiol valerate daily for 2 days, and then one dosage unit comprising a pharmaceutically acceptable placebo daily for 2 days.